2 New COVID-19 Vaccines Nearing Approval: How They’re Different
A new vaccine from Sanofi and GlaxoSmithKline is one of two being reviewed by federal regulators. Jeremy Moeller/Getty Images Novavax has asked federal regulators for emergency use authorization for its new COVID-19 vaccine.Meanwhile, Sanofi and GlaxoSmithKline are requesting full approval for their COVID-19 vaccine.Both vaccines use older technology than the mRNA vaccines currently in use.Experts say the new...